These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26006172)

  • 21. Tropism in bacterial infections: urinary tract infections.
    Roberts JA
    J Urol; 1996 Nov; 156(5):1552-9. PubMed ID: 8863537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary tract infections in patients with orthotopic neobladder.
    Mano R; Baniel J; Goldberg H; Stabholz Y; Kedar D; Yossepowitch O
    Urol Oncol; 2014 Jan; 32(1):50.e9-14. PubMed ID: 24239471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New aspects of pathogenesis of lower urinary tract infections.
    Sobel JD
    Urology; 1985 Nov; 26(5 Suppl):11-6. PubMed ID: 3904135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). II. Background of patients].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 May; 49(5):494-508. PubMed ID: 8752863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence and antimicrobial resistance of urinary tract infection isolates in febrile young children without localizing signs in Taiwan.
    Wu CT; Lee HY; Chen CL; Tuan PL; Chiu CH
    J Microbiol Immunol Infect; 2016 Apr; 49(2):243-8. PubMed ID: 26299351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort.
    Vidal E; Torre-Cisneros J; Blanes M; Montejo M; Cervera C; Aguado JM; Len O; Carratalá J; Cordero E; Bou G; Muñoz P; Ramos A; Gurguí M; Borrell N; Fortún J;
    Transpl Infect Dis; 2012 Dec; 14(6):595-603. PubMed ID: 22650416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Host Responses to Urinary Tract Infections and Emerging Therapeutics: Sensation and Pain within the Urinary Tract.
    Birder LA; Klumpp DJ
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 28087925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host-pathogen interactions mediating pain of urinary tract infection.
    Rudick CN; Billips BK; Pavlov VI; Yaggie RE; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2010 Apr; 201(8):1240-9. PubMed ID: 20225955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli.
    Tseng CC; Wu JJ; Liu HL; Sung JM; Huang JJ
    Am J Kidney Dis; 2002 Apr; 39(4):744-52. PubMed ID: 11920340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up--an observational prospective study.
    Salomon J; Denys P; Merle C; Chartier-Kastler E; Perronne C; Gaillard JL; Bernard L
    J Antimicrob Chemother; 2006 Apr; 57(4):784-8. PubMed ID: 16473921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of antibiotics resistance among uropathogens in Omani children presenting with a single episode of urinary tract infection.
    Sharef SW; El-Naggari M; Al-Nabhani D; Al Sawai A; Al Muharrmi Z; Elnour I
    J Infect Public Health; 2015; 8(5):458-65. PubMed ID: 25755002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial pathogens in first febrile urinary tract infection affect breakthrough infections in infants with vesicoureteral reflux treated with prophylactic antibiotics.
    Park S; Song SH; Lee C; Kim JW; Kim KS
    Urology; 2013 Jun; 81(6):1342-5. PubMed ID: 23562584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility.
    Koeijers JJ; Verbon A; Kessels AG; Bartelds A; Donkers G; Nys S; Stobberingh EE
    Urology; 2010 Aug; 76(2):336-40. PubMed ID: 20494416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Effects of Xyloglucan in Association with the Polysaccharide Gelose in an Experimental Model of Gastroenteritis and Urinary Tract Infections.
    Esposito E; Campolo M; Casili G; Lanza M; Franco D; Filippone A; Peritore AF; Cuzzocrea S
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29932149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity.
    Nienhouse V; Gao X; Dong Q; Nelson DE; Toh E; McKinley K; Schreckenberger P; Shibata N; Fok CS; Mueller ER; Brubaker L; Wolfe AJ; Radek KA
    PLoS One; 2014; 9(12):e114185. PubMed ID: 25486068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.
    Garofalo CK; Hooton TM; Martin SM; Stamm WE; Palermo JJ; Gordon JI; Hultgren SJ
    Infect Immun; 2007 Jan; 75(1):52-60. PubMed ID: 17074856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The value of antibody coated bacteria in the evaluation of the level of urinary tract infections].
    Demirağ MN; Atun IH; Gülmezoğlu E
    Mikrobiyol Bul; 1982 Jan; 16(1):43-52. PubMed ID: 6755199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.